| ID | Name | CAS | Properties |
logPoct/wat |
| 22-031-2 |
Acetic acid, 6(9h)-hydrazinopurin-9-yl-, hydrazide
|
|
2 | -1.898 |
| 22-594-8 |
trans-2,4-Dimethoxycinnamic acid, tert-butyldimethylsilyl ester
|
|
2 | 4.265 |
| 22-769-4 |
Silane, dimethyl(hex-4-yn-3-yloxy)propoxy-
|
|
2 | 2.933 |
| 22-988-1 |
2-Propanol, 1,3-dibromo-, phosphate (3:1)
|
|
2 | 5.620 |
| 23-101-3 |
(E)-2-Pentenoic acid, 2-propyl, trimethylsilyl ester
|
|
2 | 3.501 |
| 23-336-3 |
2'-Deoxyadenosine, 3',5'-bis-O-cyclotetramethylene-isopropylsilyl
|
|
2 | 5.396 |
| 23-341-7 |
24R,25-Dihydroxycholecalciferol, methylboronate, 3-TMS, # 2
|
|
2 | 8.744 |
| 23-364-2 |
Tropic acid, tert-butyldimethylsilyl ether, tert-butyldimethylsilyl ester
|
|
2 | 6.340 |
| 23-799-0 |
2,4-Dichlorobenzyl alcohol, (3-cyanopropyl)dimethylsilyl ether
|
|
2 | 5.019 |
| 23-837-7 |
15-Keto-PGE2, BO-TMS, isomer # 4
|
|
2 | 9.819 |
| 24-032-9 |
Mordant yellow 12, O,O'-di(tert.-butyldimethylsilyl)-
|
|
2 | 8.230 |
| 24-271-4 |
3-Amino-N-butyric acid, bis(trimethylsilyl) deriv.
|
58521-54-3 |
2 | 2.568 |
| 24-385-8 |
Urea, 1,3-bis(2-cyanoethyl)-1-nitroso-
|
60285-25-8 |
2 | 0.507 |
| 24-478-5 |
16.alpha.,17-H2 (OH)2 GA34, MeTMS
|
|
2 | 7.683 |
| 24-482-0 |
1H-Pyrazole, 4,5-dihydro-1,3-diphenyl-
|
|
2 | 3.301 |
| 24-648-6 |
Benzimidazole, 4,6-dichloro-5-nitro-2-(trifluoromethyl)-
|
6609-43-4 |
2 | 3.315 |
| 25-416-2 |
15-Keto-PGE2, EO-TMS, isomer # 2
|
|
2 | 8.259 |
| 25-655-7 |
2-N-heptyl-3,5,6-trimethyl pyrazine
|
|
2 | 3.915 |
| 25-724-0 |
2«beta»,12«alpha»-(OH)2GA25 methyl ester
|
|
2 | 4.951 |
| 25-994-1 |
5.alpha.-Androstane-3,7,17-trione, TMS
|
|
2 | 6.899 |
| 26-215-4 |
3,5-Dideoxy-erythro-pentonic acid, tris-TMS
|
|
2 | 4.215 |
| 26-325-2 |
2,3,4,5-Tetrafluorobenzyl alcohol, bromomethyldimethylsilyl ether
|
|
2 | 3.899 |
| 26-348-7 |
Silane, dimethyl(6-methyl-2-tert-butylphenoxy)heptadecyloxy-
|
|
2 | 10.261 |
| 26-805-9 |
Silane, dimethyl(dimethyl(2-ethylbutoxy)silyloxy)(2-ethylbutoxy)-
|
|
2 | 5.312 |
| 27-207-2 |
Silane, diphenylbutoxy(3-methylbut-3-en-1-yloxy)-
|
|
2 | 4.042 |
| 27-235-1 |
P-phenylazo carbanilic acid, 7,8-dihydrolinalool ester
|
|
2 | 7.566 |
| 27-294-6 |
Piperidine, 1-[(2,6-dioxo-4-piperidyl)carbonyl]-
|
|
2 | 0.052 |
| 27-322-4 |
3-Methyl-4-phenyl-4-thiazoline-2-thione
|
21402-19-7 |
2 | 3.483 |
| 27-688-9 |
«beta»-Gentiobiose, octakis(trimethylsilyl) ether, methyloxime (isomer 2)
|
|
2 | 9.752 |
| 28-047-9 |
N-(trifluoroacetyl)-o,o',o''-tris(trimethylsilyl)norepinephrine
|
|
2 | 5.685 |
| 28-298-1 |
17-Ethylenedioxy-3alpha, 5alpha-cycloandrostan-6-one oxime
|
|
2 | 4.212 |
| 28-335-9 |
Uridine, 2',3',5'-tris-O-cyclotetramethylene-tertbutylsilyl
|
|
2 | 7.357 |
| 28-343-0 |
2'-Deoxyadenosine, 3',5',N6-tris(O-TBDMSi)
|
|
2 | 7.943 |
| 28-407-9 |
Glycine, N-(2-methyl-1-oxobutyl)-, trimethylsilyl ester
|
55493-99-7 |
2 | 1.527 |
| 28-486-2 |
Silane, diphenyl(pent-4-en-2-yloxy)propoxy-
|
|
2 | 3.651 |
| 28-645-5 |
15-Keto-PGE2, MO-TMS, isomer # 3
|
|
2 | 7.479 |
| 28-804-8 |
Silane, dimethyl(non-5-yn-3-yloxy)hexyloxy-
|
|
2 | 5.274 |
| 28-963-2 |
1-(2-Quinolyl)hexahydro-2h-azepin-2-one-
|
|
2 | 3.142 |
| 29-160-2 |
1,3-Dicyclohexyl-1,1,3,3-tetramethyldisiloxane
|
62399-01-3 |
2 | 6.082 |
| 29-307-9 |
2,4-Dichloro-3,5-dimethylphenol, trimethylsilyl ether
|
|
2 | 4.824 |
| 29-318-7 |
3,6-dideoxy-arabino-hexonic acid, tetrakis-TMS
|
|
2 | 5.435 |
| 29-334-9 |
2-Fluoro-3-(trifluoromethyl)phenol, tert-butyldimethylsilyl ether
|
|
2 | 5.228 |
| 29-806-5 |
2-(tert-Butyl-dimethyl-silanyloxy)- 3-isopropyl-quinoxaline
|
|
2 | 5.137 |
| 29-959-6 |
Silane, diphenyl(non-5-yn-3-yloxy)pentyloxy-
|
|
2 | 5.439 |
| 30-052-0 |
Silane, dimethyl(non-5-yn-3-yloxy)octadecyloxy-
|
|
2 | 9.955 |
| 30-082-7 |
erythro-Hex-2-enono-1,4-lactone, TMS
|
|
2 | 4.898 |
| 30-143-9 |
5B-Cholestane-3A,7A,12A,26-tetrol, TMS
|
|
2 | 11.819 |
| 30-227-6 |
Imidazole-4-carboxamide, 5-(3'-methyl-1'-triazeno)-
|
3413-72-7 |
2 | -0.755 |
| 30-328-4 |
5A-Androstan-3B,16B,17B-triol, tris-TMS
|
|
2 | 8.299 |
| 30-329-3 |
5A-Androstan-3B,16A,17B-triol, tris-TMS
|
|
2 | 8.299 |
| 30-373-4 |
5B-Androstan-3A,16B,17B-triol, tris-TMS
|
|
2 | 8.299 |
| 30-412-0 |
2-Methyl-1-pentanol, (3-cyanopropyl)dimethylsilyl ether
|
|
2 | 3.948 |
| 30-414-8 |
Uracil, 1-{p-[3-(2-chloroethyl)ureido]benzyl}-
|
|
2 | 0.463 |
| 30-505-7 |
Arabinose, 2,3,4,5-tetrakis-O-(trimethylsilyl)-
|
1768-95-2 |
2 | 4.697 |
| 30-815-3 |
1,5-Hexadien-3-ol, tert-butyldimethylsilyl ether
|
|
2 | 4.139 |
| 30-901-7 |
Silane, diphenyl(2,4-dimethylpent-3-yloxy)propoxy-
|
|
2 | 4.367 |
| 31-061-9 |
Silane, diphenyl(non-3-en-1-yloxy)propoxy-
|
|
2 | 5.213 |
| 31-103-2 |
Silane, diphenyl(2,4-dimethylpent-3-yloxy)isohexyloxy-
|
|
2 | 5.393 |
| 31-254-5 |
(E)-3,5-Dimethoxy-4-hydroxycinnamic acid, TBDMS
|
|
2 | 5.479 |
| 31-813-4 |
7«beta»,16«alpha»,17-triOH-kauranolide, TMS
|
|
2 | 7.206 |
| 31-890-9 |
DL-Arabinose, tetrakis(trimethylsilyl) ether, trimethylsilyloxime (isomer 2)
|
|
2 | 6.335 |
| 31-891-8 |
D-Arabinose, tetrakis(trimethylsilyl) ether, trimethylsilyloxime (isomer 1)
|
|
2 | 6.335 |
| 31-912-4 |
3-(4-Diethylamino-2-hydroxyphenylazo)-4-hydroxybenzenesulfonic acid
|
1563-01-5 |
2 | 3.606 |
| 31-978-2 |
Glutaric acid, 2-oxo, 1-MO, 2TMS, MP
|
|
2 | 2.525 |
| 32-037-5 |
Estran-4-on-17B-ol, 17A-ethyl, TMS
|
|
2 | 8.129 |
| 32-064-5 |
D-(+)-Cellobiose, octakis(trimethylsilyl) ether (isomer 2)
|
|
2 | 9.476 |
| 32-081-6 |
4-Nitro-3-carbethoxy-1,2,7-trimethylindole
|
52916-05-9 |
2 | 2.880 |
| 32-338-1 |
1,2-Propanediol, 3-(3,4-methylenedioxyphenyl), DTBS
|
|
2 | 4.209 |
| 32-408-3 |
12.beta.-OH-GA51 methyl ester TMS ether
|
|
2 | 4.914 |
| 33-163-4 |
3B,16A,20A-Trihydroxypregn-5-ene, tris-TMS
|
|
2 | 8.034 |
| 33-190-4 |
16«beta»,17-H2(OH)2 GA12, MeTMSi
|
|
2 | 6.023 |
| 33-279-6 |
2-Nonenal, 3-hydroxy, TMS, PFBO, # 1
|
|
2 | 6.590 |
| 33-440-6 |
4-(tert-Butyldimethylsilyloxy)-2-(tert-butyldimethylsilylsulfanyl)-6-methylpyrimidine
|
|
2 | 6.266 |
| 33-570-2 |
Silane, dimethyl(non-5-yn-3-yloxy)ethoxy-
|
|
2 | 3.713 |
| 33-685-5 |
Flavone, 3,5-dihydroxy-7-methoxy, bis-TMS
|
|
2 | 5.896 |
| 34-200-1 |
[13C]15-epi-GA63 methyl ester TMS ether
|
|
2 | 4.914 |
| 34-568-4 |
Pyrimidine, 2-hydroxy-4-imino-3-methyl, TMS
|
|
2 | 2.369 |
| 34-605-2 |
12«beta»-OH-GA4 methyl ester TMS ether
|
|
2 | 4.914 |
| 34-648-5 |
1D-1-O-Methyl-muco-inositol, pentakis-TMS
|
|
2 | 6.115 |
| 34-826-7 |
Pyrrolidine, n-[2,6-dioxo-4-piperidinyl)acetyl]-
|
|
2 | 0.052 |
| 34-879-9 |
Silane, diphenyl(but-2-en-1-yloxy)isohexyloxy-
|
|
2 | 4.288 |
| 34-918-5 |
threo-Hex-2-enono-1,4-lactone, TMS
|
|
2 | 4.898 |
| 35-006-6 |
Silane, diphenyl(3,3-dimethylbut-2-yloxy)pentyloxy-
|
|
2 | 4.901 |
| 35-187-6 |
Imidazole, 5-(o-aminophenylthio)-1-methyl-4-nitro-
|
|
2 | 2.062 |
| 35-271-2 |
GA20-Open lactone-1(10)-ene, Me-TMS
|
|
2 | 4.642 |
| 35-583-6 |
tert-Butyldimethylsilyl 4-(2-(tert-butyldimethylsilyl)hydrazino)benzenesulfonate
|
|
2 | 5.319 |
| 35-585-4 |
DL-Arabinose, tetrakis(trimethylsilyl) ether, benzyloxime (isomer 2)
|
|
2 | 6.701 |
| 35-597-1 |
2H-azepin-2-one, hexahydro-1-(2-pyridyl)-
|
51263-32-2 |
2 | 1.989 |
| 35-687-1 |
1-(1-phenyl-4-hydroxycyclohexyl)-4-hydroxypiperidine (TMS)
|
|
2 | 5.992 |
| 35-703-2 |
2-Nonenal, 3-hydroxy, TMS, PFBO, # 2
|
|
2 | 6.590 |
| 35-722-1 |
Benzimidazole, 4,5-dichloro-6-nitro-2-(trifluoromethyl)-
|
|
2 | 3.315 |
| 35-728-5 |
D-(-)-Lyxose, tetrakis(trimethylsilyl) ether, benzyloxime (isomer 1)
|
|
2 | 6.701 |
| 35-887-9 |
l-Threonine, o-(tert-butyldimethylsilyl)-, tert-butyldimethylsilyl ester
|
|
2 | 4.272 |
| 35-968-9 |
Stanolone (5A-Androstan-17B-ol-3-one), TMS
|
|
2 | 7.594 |
| 36-055-1 |
Silane, diphenylisobutoxy(2,2,3,3,3-pentafluoropropoxy)-
|
|
2 | 4.130 |
| 36-675-3 |
Silane, diphenylbutoxy(cis-hex-3-en-1-yloxy)-
|
|
2 | 4.433 |
| 37-648-2 |
5-«beta»-Pregnan-3,17,20-triol, MeTMS
|
|
2 | 9.079 |
| 37-674-3 |
3-(4-Chlorophenyl)-3-trimethylsilyloxy-acrylonitrile (isomer 2)
|
|
2 | 4.056 |
| 37-957-9 |
(3,3,5-Trimethylcyclohexyl) 2-(tert-butyldimethylsilyloxy)benzoate
|
|
2 | 6.442 |
| 38-016-2 |
N-(2-Bromobutyryl)-4-chloro-benzenesulfonamide, N-trimethylsilyl-
|
|
2 | 3.866 |
|
« Previous Results
Next Results »
|